Near-infrared and fourier transform infrared chemometric methods for the quantification of crystalline tacrolimus from sustained-release amorphous solid Dispersion

Journal of Pharmaceutical Sciences

Volumn 103, Issue 8, 2014, Pages 2376-2385

  Rahman, Ziyaur ^a   Siddiqui, Akhtar ^a   Bykadi, Srikant ^a   Khan, Mansoor A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

amorphous; chemometrics; crystallinity; infrared spectroscopy; near infrared spectroscopy; partial least squares; principal component analysis; solid dispersion

Indexed keywords

DRUG CARRIER; ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE; TACROLIMUS; DELAYED RELEASE FORMULATION; IMMUNOSUPPRESSIVE AGENT;

ACCURACY; ANALYTIC METHOD; ARTICLE; CHEMOMETRIC ANALYSIS; DRUG MIXTURE; INFRARED SPECTROSCOPY; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; NEAR INFRARED SPECTROSCOPY; QUANTITATIVE ANALYSIS; SUSTAINED RELEASE FORMULATION; X RAY DIFFRACTION; CHEMISTRY; CRYSTALLIZATION; DELAYED RELEASE FORMULATION; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; REGRESSION ANALYSIS;

CRYSTALLIZATION; DELAYED-ACTION PREPARATIONS; IMMUNOSUPPRESSIVE AGENTS; LEAST-SQUARES ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTROSCOPY, NEAR-INFRARED; TACROLIMUS;

EID: 84905121677     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.24055     Document Type: Article

References (32)

1. Siddiqui A, Rahman Z, Sayeed VA, Khan MA,. 2013. Chemometric evaluation of near infrared, fourier transform infrared, and Raman spectroscopic models for the prediction of nimodipine polymorphs. J Pharm Sci 102: 4024-4035.
2. Bertacche V, Pini E, Stradi R, Stratta F,. 2006. Quantitative determination of amorphous cyclosporine in crystalline cyclosporine samples by Fourier transform infrared spectroscopy. J Pharm Sci 95: 159-166.
3. Blanco M, Villar A,. 2000. Polymorphic analysis of a pharmaceutical preparation by NIR spectroscopy. Analyst 125: 2311-2314.
4. Partini M, Patani R,. 2007. Determination of crystallinity of an aliphatic polyester by FTIR spectroscopy. Polym Bull 59: 403-412.
5. Rinnan A, Berg FVD, Engelsen SB,. 2009. Review of the most common pre-processing techniques for near-infrared spectra. Trends Anal Chem 28: 1201-1222.
6. Ivanisevic I, Bates S, Chen P,. 2009. Novel method for the assessment of miscibility in amorphous dispersions. J Pharm Sci 98: 3373-3386.
7. Tobyn M, Brown J, Dennis AB, Fakes M, Gao Q, Gamble J, Khimyak YZ, McGeorge G, Patel C, Sinclair W, Timmins P, Yin S,. 2009. Amorphous drug-PVP dispersions: Application of theoretical, thermal and spectroscopic analytical techniques to the study of a molecule with intermolecular bonds in both the crystalline and pure amorphous state. J Pharm Sci 98: 3456-3468.
8. Rahman Z, Khan MA,. 2013. Hunter screening design to understand the product variability of solid dispersion formulation of a peptide antibiotic. Int J Pharm 456: 572-582.
9. Rahman Z, Siddiqui A, Khan MA,. 2013. Characterization of a nonribosomal peptide antibiotic solid dispersion formulation by process analytical technologies sensors. J Pharm Sci 102: 4337-4346.
10. Khan MA, Karnachi AA, Singh SK, Sastry SV, Kislalioglu SM, Bolton S,. 1995. Controlled release coprecipitates: Formulation considerations. J Control Release 37: 131-141.
11. Filippis PD, Zingone G, Gibellini M, Rubessa F, Rupena P,. 1995. Dissolution rates of different drugs from solid dispersions with Eudragit RS. Eur J Pharm Sci 3: 265-271.
12. Ghaly ES, Hernández JI, Malavé A, Marti A,. 1993. Physicochemical characterization of acetaminophen-ethylcellulose solid dispersion. P R Health Sci J 12: 273-276.
13. Dong Z, Choi DS,. 2008. Hydroxypropyl methylcellulose acetate succinate: Potential drug-excipient incompatibility. AAPS Pharm Sci Tech 9: 991-997.
14. Hancock BC, Shamblin SL, Zografi G,. 1995. Molecular mobilityof amorphous pharmaceutical solids below their glass transition temperatures. Pharm Res 12: 799-806.
15. Marsac PJ, Konno H, Taylor LS,. 2006. A comparison of the physical stability of amorphous felodipine and nifedipine systems. Pharm Res 23: 2306-2316.
16. Crowley KJ, Zografi G,. 2003. The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state. Pharm Res 20: 1417-1422.
17. Marsac PJ, Shamblin SL, Taylor LS,. 2006. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm Res 23: 2417-2426.
18. Tamura S, Ohike A, Ibuki R, Amidon GL, Yamashita S,. 2002. Tacrolimus is a class II low-solubility high-permeability drug: The effect of P-glycopropetein efflux on regional permeability of tacrolimus in rats. J Pharm Sci 91: 719-729.
19. Janssens S, Van den Mooter G,. 2009. Review: Physical chemistry of solid dispersions. J Pharm Pharmacol 61: 1571-1586.
20. FDA Prograf® Capsule label. Accessed on June 9, 2014 at: http://www.accessdata.fda.gov/drugsatfda-docs/label/2013/050708s043, 050709s036lbl.pdf.
21. Siddiqui A, Rahman Z, Bykadi S, Khan MA,. 2014. Chemometric methods for the quantification of crystalline tacrolimus in solid dispersion by powder X-ray diffractrometry. J Pharm Sci.[Epub ahead of print.]
22. Zidan AS, Rahman Z, Sayeed V, Raw A, Yu L, Khan MA,. 2012. Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis. Int J Pharm 423: 341-450.
23. Sethia S, Squillante E,. 2004. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm 272: 1-10.
24. Hane K, Fujioka M, Namiki Y, Kitagawa T, Kihara N, Shimatani K, Yasuda T,. 1992. Physico-chemical properties of (-)-1R,9S,12S,13R,14S,17R,18E,21S,23S, 24R,25S,27R)-17-allyl-1,14-dihydroxy-12-[(E)-2-[(1R,3R,4R)-4-hydroxy-3- methoxycyclohexyl]-1-methylvinyl]-23,25-dimethoxy-13,19,21,27-tetrametyl-11, 28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone hydrate (FK-506). Iyakuhin Kenkyu 23: 33-43.
25. Yamashita K, Nakate T, Okimoto K, Ohike A, Tokunaga Y, Ibuki R, Higaki K, Kimura T,. 2003. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm 267: 79-91.
26. Raut DM, Allada R, Pavan KV, Deshpande G, Patil D, Patil A, Deshmukh A, Raut DM, Sakharkar DM, Bodke PS, Mahajan DT,. 2011. Dehydration of lactose monohydrate: Analytical and physical characterization. Der Pharmacia Lettre 3: 202-212.
27. Kirk JH, Danna SE, Blatchford CG,. 2007. Lactose: A definitive guide to polymorph determination. Int J Pharm 334: 103-114.
28. Zidan AS, Spinks C, Fortunak J, Habib M, Khan MA,. 2010. Near-infrared investigations of novel anti-HIV tenofovir liposomes. AAPS J 12: 202-214.
29. Zidan AS, Rahman Z, Habib MJ, Khan MA,. 2010. Spectral and spatial characterization of protein loaded PLGA nanoparticles. J Pharm Sci 99: 1180-1192.
30. Rahman Z, Zidan AS, Khan MA,. 2010. Non-destructive methods of characterization of risperidone solid lipid nanoparticles. Eur J Pharm Biopharm 76: 127-137.
31. Rahman Z, Siddiqui A, Khan MA,. 2013. Orally disintegrating tablet of novel salt of antiepileptic drug: Formulation strategy and evaluation. Eur J Pharm Biopharm 85: 1300-1309.
32. Maribeli FM,. 1993. Principles, theory, and practice of internal reflection spectroscopy, internal reflection spectroscopy-theory and applications. In Internal reflection spectroscopy: Theory and application;, Mirabella FM Jr, Ed. New York: Marcel Dekker, Inc., pp 17-52.